AGILON HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against agilon health, inc. - AGL

NEW ORLEANS, May 10, 2024 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 20, 2024 to file lead plaintiff applications in securities class action lawsuits against agilon health, inc. ("agilon" or the "Company") (NYSE: AGL), if they: i) purchased or otherwise acquired the Company's shares between April 15, 2021 and February 27, 2024, inclusive (the "Class Period"), and/or ii) purchased or otherwise acquired the Company's shares pursuant or traceable to the Company's April 2021 initial public offering ("IPO"), and/or iii) purchased or otherwise acquired the Company's shares pursuant or traceable to the Company's May 2023 secondary public offering ("SPO"). These actions are pending in the United States District Courts for the Western District of Texas and Southern District of New York.

What You May Do

If you purchased or otherwise acquired shares of agilon as above and would like to discuss your legal rights and how these cases might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-agl/ to learn more. If you wish to serve as a lead plaintiff in the class actions, you must petition the Courts by May 20, 2024.

About the Lawsuits

Agilon and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

On January 5, 2024, the Company disclosed that it was slashing its 2023 profit forecasts, specifically, lowering its 2023 Medical Margin expectation to "$340 million to $360 million, approximately $110 million below the previous guidance range…due to $90 million in higher-than-expected medical costs" and that its Chief Financial Officer, Timothy Bensley would retire and be replaced later in the year.

On this news, the price of agilon's shares fell $3.45, or 28.6%, to close at $8.63 on January 5, 2024.

The first-filed case is New England Teamsters Pension Fund v. agilon health, inc., 24-cv-00297. A second case, Hope v. agilon health, inc., 24-cv-00305, extended the Class Period. A third case, Indiana Public Retirement System v. agilon health, inc., 24-cv- 2506, extended the Class Period and Class Definition.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana and New Jersey.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

SOURCE Kahn Swick & Foti, LLC